XVIVO Perfusion AB

XVIVO Perfusion AB is a medical technology company dedicated to extending the life of major organs through innovative preservation and perfusion technologies, enabling transplant teams worldwide to save more lives. Founded in 1998 and headquartered in Gothenburg, Sweden, it leads globally in lung preservation with products like PERFADEX Plus for cold storage and XPS with STEEN Solution for machine perfusion. The company is the European leader in liver perfusion via Liver Assist and has launched transportable kidney devices using its proprietary Hypothermic Oxygenated Perfusion (HOPE) method, which extends organ viability, reduces complications, and supports longer transport times. XVIVO is introducing heart preservation technology, anticipated for European launch in 2025, comprising machines, disposables, and specialized solutions. Its offerings span thoracic and abdominal machine perfusion, organ recovery services with 24/7 teams, and advanced communication software like FlowHawk. Backed by clinical evidence from journals such as The Lancet and New England Journal of Medicine, XVIVO addresses the global organ shortage—where only 10% of demand is met—by improving marginal organ utilization, generating cost savings for healthcare systems, and fostering growth in transplantation across lung, heart, liver, and kidney sectors.